Ablatus Therapeutics

Norwich, England, United Kingdom

https://ablatus.co.uk/

Company profile

Ablatus Therapeutics company profile

Ablatus Therapeutics Ltd, a medical device company, has been founded to develop and commercialise a novel tissue ablation technology to treat the most challenging and often inoperable, solid cancer tumours.

Business identity

Website: https://ablatus.co.uk/
Operating status: Closed
Company type: For Profit
Employee range: 00001-00010 employees
Revenue range: $1K+
Founded: 2015-01-01

Headquarters

Headquarters: Norwich, England, United Kingdom
Postal code: NR3 1RU
Country code: GB
Continent: Europe

Capital profile

Funding and company signals

Funding rounds: 4
Total equity funding: $2.1M
Last funding: Series Unknown / $118K / 2021-06-28
Last equity funding: Series Unknown / $118K
Investors: 4
Lead investors: 4
Founders: 1
Articles: 7

Categories and groups

Developer Platform Innovation Management Medical Device Health Care Professional Services Software

Founders and investors

Founders

David Brooks

Lead investors

Anglia Capital GroupInnovate UKLow Carbon Innovation FundNVM Private Equity

Investors

Anglia Capital GroupInnovate UKLow Carbon Innovation FundNVM Private Equity

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.